Company's first-of-a-kind intelligent imaging system aims to expand patient access, streamline

公司首创的智能成像系统旨在扩大患者可及性，简化流程

high-quality cardiac care, and establish the foundation for future robotic interventions

高质量的心脏护理，并为未来的机器人干预奠定基础

LOS GATOS, Calif.

加利福尼亚州洛斯加托斯

,

，

Nov. 4, 2026

2026年11月4日

/PRNewswire/ --

/美通社/ --

Laza Medical, Inc.

Laza医疗公司

, a Shifamed portfolio company pioneering AI-powered robotic imaging solutions for cardiac interventions, today announced it has raised up to $160 million in Series B structured financing. GE HealthCare led the round, with participation from returning investors Unorthodox Ventures, PA MedTech, and AMED.

Shifamed旗下专注于开创用于心脏介入治疗的AI驱动机器人成像解决方案的 portfolio 公司，今日宣布已完成高达1.6亿美元的B轮结构化融资。本轮融资由GE医疗领投，原有投资者Unorthodox Ventures、PA MedTech和AMED参与跟投。

The financing will support the company's mission to transform the cardiac catheterization laboratory through intelligent imaging technology designed to simplify procedures, increase autonomy, alleviate resource constraints, and unlock the possibilities for future robotic-enabled interventions..

此次融资将支持公司通过智能影像技术变革心脏导管室的使命，该技术旨在简化手术流程、提升自主性、缓解资源限制，并释放未来机器人辅助介入治疗的潜力。

'The future of cardiac intervention must be one where access, consistency, and quality of care are no longer barriers to better outcomes,' stated Jyoti Gera, CEO of Cardiovascular and Interventional Solutions, Advanced Imaging Solutions at GE HealthCare. 'Integrating imaging modalities so they work seamlessly together has the potential to redefine the cath lab, enabling more efficient workflows today and paving the way for smarter, robotic procedures tomorrow.

“心脏介入的未来必须是一个让可及性、一致性和护理质量不再成为改善预后障碍的时代，”GE医疗心血管与介入解决方案及高级成像解决方案首席执行官Jyoti Gera表示。“将各种影像模态整合以实现无缝协同，有望重新定义导管室，既能在当下提升工作流程效率，也为未来更智能的机器人手术铺平道路。”

We're excited to expand our collaboration with Laza and work together toward this shared vision.'.

我们很高兴能够扩大与 Laza 的合作，并携手实现这一共同愿景。

As cardiovascular procedures become increasingly complex, care teams need more intuitive and consistent image guidance amid growing demands for specialized imaging expertise. By combining AI and robotics, Laza has the potential to simplify procedural imaging, extend the reach of specialized imaging expertise, and help care teams navigate and guide complex cardiac interventions with greater confidence..

随着心血管手术日益复杂，在对专业影像专业知识的需求不断增长的背景下，护理团队需要更加直观和一致的影像引导。通过结合人工智能与机器人技术，Laza有望简化手术影像流程，扩大专业影像专业知识的覆盖范围，并帮助护理团队以更强的信心导航和引导复杂的心脏介入手术。

'High-quality imaging is foundational to all successful cases,' said Dr. Firas Zahr, Head of Interventional Cardiology at Oregon Health Sciences University Hospital, who had experience with the software during the

“高质量影像是所有成功病例的基础，”俄勒冈健康与科学大学医院介入心脏病学主任菲拉斯·扎尔博士表示，他在

first-in-human clinical study

首次人体临床试验

last year. 'Consistent anatomic and spatial context simplifies procedures and helps clinicians navigate the anatomy with confidence and precision.'

去年。“一致的解剖和空间背景简化了操作流程，帮助临床医生以信心和精度进行解剖导航。”

'The cath lab is poised for a fundamental evolution, and intelligent imaging powered by AI will play a defining role in what comes next,' said Amr Salahieh, Founder and Board Chairman at Laza Medical. 'As we reimagine the role of imaging in interventional care, we are grateful for the strong support from our investors, which validates our approach and reinforces our conviction that this solution will streamline processes, reduce variability, and ultimately improve the quality and reach of cardiac procedures.'.

“导管室正迎来一场根本性的变革，而由人工智能驱动的智能成像将在未来的发展中发挥决定性作用，”Laza Medical 创始人兼董事会主席 Amr Salahieh 表示。“在我们重新构想成像技术在介入治疗中的角色之际，我们感谢投资者给予的大力支持，这不仅验证了我们的方法，也进一步坚定了我们的信念：该解决方案将简化流程、减少变异性，并最终提升心脏手术的质量与可及性。”

The Laza Medical System is under development and is not approved for commercial sale in any geography.

Laza 医疗系统正在开发中，尚未在任何地区获批用于商业销售。

About Laza Medical, Inc.

关于 Laza Medical, Inc.

Laza Medical is a privately held portfolio company of

Laza Medical 是一家私人持股的投资组合公司，隶属于

Shifamed, LLC

Shifamed 有限责任公司

. The company focuses on developing a high-quality, AI-powered robotic imaging solution for cardiovascular interventions. For more information, visit

该公司专注于开发用于心血管介入治疗的高质量、人工智能驱动的机器人成像解决方案。欲了解更多信息，请访问

www.lazamedical.com

www.lazamedical.com

.

。

About Shifamed, LLC

关于 Shifamed, LLC

Founded by serial entrepreneur Amr Salahieh, Shifamed is a highly specialized medical innovation hub focused on developing solutions that accelerate time to market, reduce risk, increase impact, and forge a path toward a world where patients are able to lead longer, healthier lives.

Shifamed 由连续创业者 Amr Salahieh 创立，是一家高度专业化的医疗创新中心，专注于开发能够加速产品上市、降低风险、扩大影响力，并为实现患者享有更长寿、更健康生活的世界开辟道路的创新解决方案。

Shifamed's goal is to lead the way in next generation of cardiac cath lab innovation, bringing together breakthroughs in advanced imaging, artificial intelligence (AI), and robotics to transform how interventional cardiovascular procedures are performed.

Shifamed 的目标是引领下一代心脏导管室创新，将先进成像、人工智能（AI）和机器人技术的突破融合在一起，从而变革介入性心血管手术的实施方式。

Media Contact

媒体联系人

Charlene Herndon

查琳·赫恩登

SPRIG Consulting

SPRIG 咨询公司

charlene@sprigconsulting.com

charlene@sprigconsulting.com

SOURCE Laza Medical, Inc.

来源：Laza Medical, Inc.